Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma

ISSN： 1479-6694

Source： Future Oncology, Vol.4, Iss.2, 2008-04, pp. : 169-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addressing the Incremental Benefit of Histamine Dihydrochloride When Added to Interleukin-2 in Treating Acute Myeloid Leukemia: A Bayesian Meta-Analysis

By Berry Scott M. Broglio Kristine R. Berry Donald A.

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 293-299

Informa Healthcare

Access to resources Recommend Favorite

Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation

By Jones Cortney V Copelan Edward A

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 559-568

Future Medicine

Access to resources Recommend Favorite

Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 407-412

Spandidos Publications

Access to resources Recommend Favorite

Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia

By DiNardo Courtney D O'Brien Susan Gandhi Varsha V Ravandi Farhad

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1073-1082

Future Medicine

Access to resources Recommend Favorite

Clofarabine for the treatment of adult acute myeloid leukemia

By Thomas Xavier Raffoux Emmanuel Elhamri Mohamed Lobe Ida Cannas Giovanna Dombret Hervéé

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1197-1210

Future Medicine

Access to resources Recommend Favorite